SC 13G 1 jan13-g.txt \MISC\JANUARY ADVANTAGE-CELSCI 13G\ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 3)* Cel Sci Corporation -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, $.01 par value per share -------------------------------------------------------------------------------- (Title of Class of Securities) 150837 40 9 -------------- (CUSIP Number) December 31, 2001 -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [X] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 10 ----------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only) Advantage Fund II Ltd. ----------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] (See Item 6) ----------------------------------------------------------------------------- 3 SEC USE ONLY ----------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION British Virgin Islands ----------------------------------------------------------------------------- NUMBER OF 5 SOLE VOTING POWER SHARES -0- -------------------------------------------------------------- BENEFICIALLY 6 SHARED VOTING POWER OWNED BY 2,332,099 shares of Common Stock -------------------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING -0- -------------------------------------------------------------- PERSON 8 SHARED DISPOSITIVE POWER WITH 2,332,099 shares of Common Stock ----------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,332,099 shares of Common Stock ----------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [X] ----------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.99% ----------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* CO ----------------------------------------------------------------------------- * SEE INSTRUCTIONS BEFORE FILLING OUT! Page 2 of 10 ----------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only) Genesee International, Inc. ----------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] (See Item 6) ----------------------------------------------------------------------------- 3 SEC USE ONLY ----------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware ----------------------------------------------------------------------------- NUMBER OF 5 SOLE VOTING POWER SHARES -0- -------------------------------------------------------------- BENEFICIALLY 6 SHARED VOTING POWER OWNED BY 2,332,099 shares of Common Stock -------------------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING -0- -------------------------------------------------------------- PERSON 8 SHARED DISPOSITIVE POWER WITH 2,332,099 shares of Common Stock ----------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,332,099 shares of Common Stock ----------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [X] ----------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.99% ----------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* CO ----------------------------------------------------------------------------- Page 3 of 10 ----------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only) Donald R. Morken ----------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] (See Item 6) ----------------------------------------------------------------------------- 3 SEC USE ONLY ----------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States of America ----------------------------------------------------------------------------- NUMBER OF 5 SOLE VOTING POWER SHARES -0- -------------------------------------------------------------- BENEFICIALLY 6 SHARED VOTING POWER OWNED BY 2,332,099 shares of Common Stock -------------------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING -0- -------------------------------------------------------------- PERSON 8 SHARED DISPOSITIVE POWER WITH 2,332,099 shares of Common Stock ----------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,332,099 shares of Common Stock ----------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [X] ----------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.99% ----------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* IN ----------------------------------------------------------------------------- Page 4 of 10 Item 1(a). Name of Issuer: Cel Sci Corporation (the "Corporation"). Item 1(b). Address of Issuer's Principal Executive Offices: 8229 Boone Boulevard, Suite 802, Vienna, Virginia 22182. Item 2(a). Name of Person Filing: Advantage Fund II Ltd. ("Advantage") Genesee International, Inc. ("Genesee") Donald R. Morken ("Morken") (collectively, the "Reporting Person") Item 2(b). Address of Principal Business Office or, if None, Residence: Advantage - C/O CITCO, Kaya Flamboyan 9, Curacao, Netherlands Antilles. Genesee - CITCO Building, Wickhams Cay, P.O.Box 662, Road Town, Tortola, British Virgin Islands. Morken - 10500 N.E. 8th Street, Suite 1920, Bellevue, Washington 98004-4332. Item 2(c). Citizenship: Advantage - British Virgin Islands. Genesee - Delaware. Morken - United States of America. Item 2(d). Title of Class of Securities: Common Stock, par value $.01 per share of the Company (the "Common Stock"). Item 2(e). CUSIP Number: 150837 40 9 Item 3. If This Statement Is Filed Pursuant to Rules 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: (a) Broker or dealer registered under Section 15 of the Exchange Act; (b) Bank as defined in Section 3(a)(6) of the Exchange Act; (c) Insurance company as defined in Section 3(a)(19) of the Exchange Act; (d) Investment company registered under Section 8 of the Investment Company Act; (e) An investment advisor in accordance with Rule 13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; (i) A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act; (j) Group, in accordance with Rule 13d-1(b)(1)(ii)(J). If this statement is filed pursuant to Rule 13d-1(c), check this box. [X] Item 4. Ownership by Reporting Person. Provide the following information regarding the aggregate number and percentages of securities of the issuer identified in Item 1. Page 5 of 10 (a) Amount beneficially owned: 2,332,099 shares of Common Stock* (b) Percent of class: 9.99% (based on 23,344,342 shares of Common Stock outstanding as of December 20, 2001 as reported in the Company's Form10-K filed by the Company on December 31, 2001). (c) Number of shares to which such person has: (i) Sole power to vote or direct the vote: -0- (ii) Shared power to vote or direct the vote: 2,332,099 shares of Common Stock* (iii) Sole power to dispose or to direct the disposition of: -0- (iv) Shared power to dispose or direct the disposition of: 2,332,099 shares of Common Stock* Item 5. Ownership of Five Percent or Less of a Class. Not Applicable Item 6. Ownership of More than Five Percent on Behalf of Another Person. Pursuant to an investment management agreement between Genesee and Advantage, Genesee has the power to sell or vote on behalf of Advantage, some or all of the shares of Common Stock to which this report relates. As such, under Rule 13d-3(a), Genesee may be deemed to be the beneficial owner of such shares. Morken is the President of Genesee and has the power to sell or vote on behalf of Genesee and Advantage, some or all of the shares of Common Stock to which this report _____________________ * Does not include certain shares of Common Stock issuable to the Reporting Person upon: (i) conversion of certain shares of preferred stock issued to the Reporting Person by the Company and (ii) exercise of certain common stock purchase warrants issued to the Reporting Person by the Company. The holder of such shares of preferred stock and common stock purchase warrants is prohibited from converting or exercising such securities for shares of Common Stock to the extent that such conversion or exercise would result in such holder, together with any affiliate thereof, beneficially owning in excess of 9.99% of the outstanding shares of Common Stock following such conversion or exercise. This restriction may be waived by the holder of such securities on not less than 61 days' notice to the Company. Page 6 of 10 relates. As such, under Rule 13d-3(a), Morken may be deemed to be the beneficial owner of such shares. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on the Parent Holding Company. Not Applicable Item 8. Identification and Classification of Members of the Group. Not Applicable Item 9. Notice of Dissolution of Group. Not Applicable Item 10. Certification. By signing below, the undersigned certify that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect. Page 7 of 10 Exhibits: Exhibit I: Joint Filing Agreement, dated as of January 25, 2002, by and among Advantage, Genesee and Morken. Page 8 of 10 Exhibit I JOINT FILING AGREEMENT This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership of the undersigned of the Common Shares, $.01 par value per share, of Cel Sci Corporation, a Colorado corporation, is being filed, and all amendments thereto will be filed, on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Dated as of January 25, 2002. ADVANTAGE FUND II LTD. By: GENESEE INTERNATIONAL, INC. As General Manager /s/ Donald R. Morken -------------------------- By: Donald R. Morken Title: President GENESEE INTERNATIONAL, INC. /s/ Donald R. Morken -------------------------- By: Donald R. Morken Title: President DONALD R. MORKEN /s/ Donald R. Morken -------------------------- Page 9 of 10 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. ADVANTAGE FUND II LTD. By: GENESEE INTERNATIONAL, INC. As General Manager /s/ Donald R. Morken -------------------------- By: Donald R. Morken Title: President GENESEE INTERNATIONAL, INC. /s/ Donald R. Morken -------------------------- By: Donald R. Morken Title: President DONALD R. MORKEN By: /s/ Donald R. Morken -------------------------- Page 10 of 10